✦ LIBER ✦

Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas

✍ Scribed by S. Tsagarakis; E. Tsiganou; I. Tzavara; H. Nikolou; N. Thalassinos

Book ID: 114720288
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 549 KB
Volume: 42
Category: Article
ISSN: 0300-0664
DOI: 10.1111/j.1365-2265.1995.tb02685.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Control of prolactin-secreting macroaden

Control of prolactin-secreting macroadenomas with parenteral, long-acting bromocriptine in 30 patients treated for up to 3 years

✍ Roland Haase; Christian Jaspers; Heinrich Maria Schulte; Ioana Lancranjan; Henri 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 960 KB

Efficacy of a new long-acting injectable

Efficacy of a new long-acting injectable form of bromocriptine in hyperprolactinaemic patients

✍ M. D. Paganl; F. Tengattini; M. Montini; G. Pagani; A. Pedroncelli; D. Gianola; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

Pharmacokinetics of a long-acting bromoc

Pharmacokinetics of a long-acting bromocriptine preparation (Parlodel LA) and its effect on release of prolactin and growth hormone

✍ E. Pozo; K. Schlüter; E. Nüesch; J. Rosenthaler; L. Kerp 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 529 KB

RAPID AND LONG-LASTING SUPPRESSION OF PR

RAPID AND LONG-LASTING SUPPRESSION OF PROLACTIN SECRETION AND SHRINKAGE OF PROLACTINOMAS AFTER INJECTION OF LONG-ACTING REPEATABLE FORM OF BROMOCRIPTINE (PARLODEL LAR)

✍ GENNARO SCHETTINI; GAETANO LOMBARDI; BARTOLOMEO MEROLA; ANNAMARIA COLAO; PAOLO M 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Results of endoscopic transsphenoidal pi

Results of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenoma

✍ Margreet Albertina E. M. Wagenmakers; Romana T. Netea-Maier; Erik J. van Lindert 📂 Article 📅 2011 🏛 Springer Vienna 🌐 English ⚖ 179 KB

## Objective Transsphenoidal pituitary surgery (TS) is the primary treatment of choice for patients with acromegaly. Macroadenomas (>1 cm) are more difficult to resect than microadenomas (remission rate ± 50% compared to ± 90%). Besides the conventional microscopic TS, the more recently introduced

Long-term treatment with a new repeatabl

Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia

✍ E. Ciccarelli; C. Miola; T. Avataneo; F. Camanni; G.M. Besser; A. Grossman 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 129 KB